Literature DB >> 31858137

Non-invasive diagnosis of H3 K27M mutant midline glioma.

Raymond Y Huang1, Jeffrey P Guenette1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31858137      PMCID： PMC7058438          DOI： 10.1093/neuonc/noz240

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.

Authors:  Xiaorui Su; Ni Chen; Huaiqiang Sun; Yanhui Liu; Xibiao Yang; Weina Wang; Simin Zhang; Qiaoyue Tan; Jingkai Su; Qiyong Gong; Qiang Yue
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

2.  Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.

Authors:  Andrew S Chi; Rohinton S Tarapore; Matthew D Hall; Nicole Shonka; Sharon Gardner; Yoshie Umemura; Ashley Sumrall; Ziad Khatib; Sabine Mueller; Cassie Kline; Wafik Zaky; Soumen Khatua; Shiao-Pei Weathers; Yazmin Odia; Toba N Niazi; Doured Daghistani; Irene Cherrick; David Korones; Matthias A Karajannis; Xiao-Tang Kong; Jane Minturn; Angela Waanders; Isabel Arillaga-Romany; Tracy Batchelor; Patrick Y Wen; Krystal Merdinger; Lee Schalop; Martin Stogniew; Joshua E Allen; Wolfgang Oster; Minesh P Mehta
Journal:  J Neurooncol       Date:  2019-08-27       Impact factor: 4.130

3.  Imaging characteristics of adult H3 K27M-mutant gliomas.

Authors:  Tianming Qiu; Apisara Chanchotisatien; Zhiyong Qin; Jinsong Wu; Zunguo Du; Xialing Zhang; Fangyuan Gong; Zhenwei Yao; Shuguang Chu
Journal:  J Neurosurg       Date:  2019-11-15       Impact factor: 5.115

4.  Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.

Authors:  Hong Chen; Wanming Hu; Haoqiang He; Yuanzhong Yang; Ge Wen; Xiaofei Lv
Journal:  Eur J Radiol       Date:  2019-03-14       Impact factor: 3.528

5.  Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.

Authors:  Sebastian R van der Voort; Fatih Incekara; Stefan Klein; Marion Smits; Maarten M J Wijnenga; Georgios Kapas; Mayke Gardeniers; Joost W Schouten; Martijn P A Starmans; Rishie Nandoe Tewarie; Geert J Lycklama; Pim J French; Hendrikus J Dubbink; Martin J van den Bent; Arnaud J P E Vincent; Wiro J Niessen
Journal:  Clin Cancer Res       Date:  2019-09-23       Impact factor: 12.531

6.  In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.

Authors:  Hamed Akbari; Spyridon Bakas; Jared M Pisapia; MacLean P Nasrallah; Martin Rozycki; Maria Martinez-Lage; Jennifer J D Morrissette; Nadia Dahmane; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

7.  Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.

Authors:  Michael Karremann; Gerrit H Gielen; Marion Hoffmann; Maria Wiese; Niclas Colditz; Monika Warmuth-Metz; Brigitte Bison; Alexander Claviez; Dannis G van Vuurden; André O von Bueren; Marco Gessi; Ingrid Kühnle; Volkmar H Hans; Martin Benesch; Dominik Sturm; Rolf-Dieter Kortmann; Andreas Waha; Torsten Pietsch; Christof M Kramm
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

8.  Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.

Authors:  Jo Sung Jung; Yoon Seong Choi; Sung Soo Ahn; Seong Yi; Se Hoon Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2019-01-20       Impact factor: 2.804

9.  Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.

Authors:  Biqi Zhang; Ken Chang; Shakti Ramkissoon; Shyam Tanguturi; Wenya Linda Bi; David A Reardon; Keith L Ligon; Brian M Alexander; Patrick Y Wen; Raymond Y Huang
Journal:  Neuro Oncol       Date:  2016-06-26       Impact factor: 13.029
  9 in total
  2 in total

1.  Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features.

Authors:  Da-Biao Deng; Yu-Ting Liao; Jiang-Fen Zhou; Li-Na Cheng; Peng He; Sheng-Nan Wu; Wen-Sheng Wang; Quan Zhou
Journal:  Front Neurol       Date:  2022-05-02       Impact factor: 4.086

2.  Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.

Authors:  Qian Li; Fei Dong; Biao Jiang; Minming Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.